lgtC expression modulates resistance to C4b deposition on an invasive nontypeable Haemophilus influenzae

Journal of Immunology

Volumn 178, Issue 2, 2007, Pages 1002-1012

  Ho, Derek K ^a,b   Ram, Sanjay ^c   Nelson, Kevin L ^b   Bonthuis, Paul J ^b   Smith, Arnold L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4B; LIPOOLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT DEPOSITION; COMPLEMENT FIXATION; GENE; GENE EXPRESSION; GENE INACTIVATION; GENE INSERTION; HAEMOPHILUS INFLUENZAE; HOST RESISTANCE; HUMAN; IMMUNOBLOTTING; LGTC GENE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33846199967     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.2.1002     Document Type: Article

References (39)

1. Cuthill, S. L., M. M. Farley, and L. G. Donowitz. 1999. Nontypable Haemophilus influenzae meningitis. Pediatr. Infect. Dis. J. 18: 660-662.
2. Nizet, V., K. F. Colina, J. R. Almquist, C. E. Rubens, and A. L. Smith. 1996. A virulent nonencapsulated Haemophilus influenzae. J. Infect. Dis. 173: 180-186.
3. O'Neill, J. M., J. W. St. Gerne, 3rd, D. Cutter, E. E. Adderson, J. Anyanwu, R. F. Jacobs, and G. E. Schutze. 2003. Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas. J. Clin. Microbiol. 41: 3064-3069.
4. Campos, J., M. Hernando, F. Roman, M. Perez-Vazquez, B. Aracil, J. Oteo, E. Lazaro, and F. de Abajo. 2004. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J. Clin. Microbiol. 42: 524-529.
5. Cerquetti, M., M. L. Ciofi degli Atti, G. Renna, A. E. Tozzi, M. L. Garlaschi, and P. Mastrantonio. 2000. Characterization of non-type B Haemophilus influenzae strains isolated from patients with invasive disease. The HI Study Group. J. Clin. Microbiol. 38: 4649-4652.
6. Erwin, A. L., K. L. Nelson, T. Mhlanga-Mutangadura, P. J. Bonthuis, J. L. Geelhood, G. Morlin, W. C. Unrath, J. Campos, D. W. Crook, M. M. Farley, et al. 2005. Characterization of genetic and phenotypic diversity of invasive non-typeable Haemophilus influenzae. Infect. Immun. 73: 5853-5863.
7. Walport, M. J. 2001. Complement: first of two parts. N. Engl. J. Med. 344: 1058-1066.
8. Fujita, T., M. Matsushita, and Y. Endo. 2004. The lectin-complement pathway-its role in innate immunity and evolution. Immunol. Rev. 198: 185-202.
9. Morgan, B. P., and C. Harris. 1999. Complement Regulatory Proteins. Academic Press, London.
10. Kraiczy, P., and R. Wurzner. 2006. Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol. Immunol. 43: 31-44.
11. Fasano, M. B., P. Densen, R. H. McLean, and J. A. Winkelstein. 1990. Prevalence of homozygous C4B deficiency in patients with deficiencies of terminal complement components and meningococcemia. J. Infect. Dis. 162: 1220-1221.
12. Winkelstein, J. A., and E. R. Moxon. 1992. The role of complement in the host's defense against Haemophilus influenzae. J. Infect. Dis. 165(Suppl. 1): S62-S65.
13. Crosson, F. J., Jr., J. A. Winkelstein, and E. R. Moxon. 1976. Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis. Infect. Immun. 14: 882-887.
14. Corrall, C. J., J. A. Winkelstein, and E. R. Moxon. 1982. Participation of complement in host defense against encapsulated Haemophilus influenzae types a, c, and d. Infect. Immun. 35: 759-763.
15. Zwahlen, A., J. A. Winkelstein, and E. R. Moxon. 1983. Participation of complement in host defense against capsule-deficient Haemophilus influenzae. Infect. Immun. 42: 708-715.
16. Williams, B. J., G. Morlin, N. Valentine, and A. L. Smith. 2001. Serum resistance in an invasive, nontypeable Haemophilus influenzae strain. Infect. Immun. 69: 695-705.
17. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76: 4350-4354.
18. Sharetzsky, C., T. D. Edlind, J. J. LiPuma, and T. L. Stall. 1991. A novel approach to insertional mutagenesis of Haemophilus influenzae. J. Bacteriol. 173: 1561-1564.
19. Herriott, R. M., E. M. Meyer, and M. Vogt. 1970. Defined nongrowth media for stage II development of competence in Haemophilus influenzae. J. Bacteriol 101: 517-524.
20. Daines, D. A., and A. L. Smith. 2001. Design and construction of a Haemophilus influenzae conjugal expression system. Gene 281: 95-102.
21. Steinhart, W. L., and R. M. Herriott. 1968. Genetic integration in the heterospecific transformation of Haemophilus influenzae cells by Haemophilus parainfluenzae deoxyribonucleic acid. J. Bacteriol. 96: 1725-1731.
22. Jones, P. A., N. M. Samuels, N. J. Phillips, R. S. Munson, Jr., J. A. Bozue, J. A. Arseneau, W. A. Nichols, A. Zaleski, B. W. Gibson, and M. A. Apicella. 2002. Haemophilus influenzae type b strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation. J. Bid. Chem. 277: 14598-14611.
23. Lesse, A. J., A. A. Campagnari, W. E. Bittner, and M. A. Apicella. 1990. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J. Immunol. Methods 126: 109-117.
24. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119: 115-119.
25. Bayliss, C. D., D. Field, and E. R. Moxon. 2001. The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis. J. Clin. Invest. 107: 657-662.
26. Erwin, A. L., S. Allen, D. K. Ho, P. J. Bonthius, J. Jarisch, K. L. Nelson, D. L. Tsao, W. C. Unrath, M. E. Watson, Jr., B. W. Gibson, et al. 2006. Role of lgtC in resistance to human serum of nontypeable Haemophilus influenzae strain R2866. Infect. Immun. 74: 6226-6235.
27. Meats, E., E. J. Feil, S. Stringer, A. J. Cody, R. Goldstein, J. S. Kroll, T. Popovic, and B. G. Spratt. 2003. Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J. Clin. Microbiol. 41: 1623-1636.
28. Noel, G. J., S. Katz, and P. J. Edelson. 1988. Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity. J. Infect. Dis. 157: 85-90.
29. Ram, S., A. D. Cox, J. C. Wright, U. Vogel, S. Getzlaff, R. Boden, J. Li, J. S. Plested, S. Meri, S. Gulati, et al. 2003. Neisserial lipooligosaccharide is a target for complement component C4b: inner core phosphoethanolamine residues define C4b linkage specificity. J. Biol. Chem. 278: 50853-50862.
30. Lee, C. H., and C. M. Tsai. 1999. Quantification of bacterial lipopolysaccharides by the purpald assay: measuring formaldehyde generated from 2-keto-3-deoxyoctonate and heptose at the inner core by periodate oxidation. Anal. Biochem. 267: 161-168.
31. Gronow, S., W. Brabetz, B. Lindner, and H. Brade. 2005. OpsX from Haemophilus influenzae represents a novel type of heptosyltransferase T in lipopolysaccharide biosynthesis. J. Bacteriol. 187: 6242-6247.
32. Hood, D. W., K. Makepeace, M. E. Deadman, R. F. Rest, P. Thibault, A. Martin, J. C. Richards, and E. R. Moxon. 1999. Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain distribution, influence on serum resistance and structural characterization. Mol. Microbiol. 33: 679-692.
33. Weiser, J. N., and N. Pan. 1998. Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide. Mol. Microbiol. 30: 767-775.
34. Hood, D. W., A. D. Cox, M. Gilbert, K. Makepeace, S. Walsh, M. E. Deadman, A. Cody, A. Martin, M. Mansson, E. K. Schweda, et al. 2001. Identification of a lipopolysaccharide α-2,3-sialyltransferase from Haemophilus influenzae. Mol. Microbiol. 39: 341-350.
35. Fox, K. L., H. H. Yildirim, M. E. Deadman, E. K. Schweda, E. R. Moxon, and D. W. Hood. 2005. Novel lipopolysaccharide biosynthetic genes containing tetranucleotide repeats in Haemophilia influenzae, identification of a gene for adding O-acetyl groups. Mol. Microbiol. 58: 207-216.
36. Weiser, J. N., N. Pan, K. L. McGowan, D. Musher, A. Martin, and J. Richards. 1998. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187: 631-640.
37. Hood, D. W., M. E. Deadman, M. P. Jennings, M. Bisercic, R. D. Fleischmann, J. C. Venter, and E. R. Moxon. 1996. DNA repeats identify novel virulence genes in Haemophilus influenzae. Proc. Natl. Acad. Sci. USA 93: 11121-11125.
38. Wilcox, K. W., and H. O. Smith. 1975. Isolation and characterization of mutants of Haemophilus influenzae deficient in an adenosine 5′-triphosphate-dependent deoxyribonuclease activity. J. Bacteriol. 122: 443-453.
39. Griffin, R., A. D. Cox, K. Makepeace, J. C. Richards, E. R. Moxon, and D. W. Hood. 2005. Elucidation of the monoclonal antibody 5G8-reactive, virulence-associated lipopolysaccharide epitope of Haemophilus influenzae and its role in bacterial resistance to complement-mediated killing. Infect. Immun. 73: 2213-2221.